Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies

Journal of Rheumatology

Volumn 33, Issue 9, 2006, Pages 1873-1877

  Harel, Liora ^a,b   Sandborg, Christy ^c   Lee, Tzielan ^c   Von Scheven, Emily ^d  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiphospholipid antibodies; Children; Neuropsychiatric; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ACUTE CONFUSION; ADOLESCENT; ADULT; ANXIETY; ASEPTIC MENINGITIS; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CHILD; COGNITIVE DEFECT; COHORT ANALYSIS; CRANIAL NEUROPATHY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PREVALENCE; PRIORITY JOURNAL; PSEUDOTUMOR; PSYCHOSIS; REAGIN TEST; RETROSPECTIVE STUDY; REVIEW; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CALIFORNIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 33748524859     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Quintero-Del-Rio AI, Van M. Neurologic symptoms in children with systemic lupus erythematosus. J Child Neurol 2000;15:803-7.
2. Steinlin MI, Blaser SI, Gilday DL, et al. Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol 1995;13:191-7.
3. Parikh S, Swaiman KF, Kim Y. Neurologic characteristics of childhood lupus erythematosus. Pediatr Neurol 1995;13:198-201.
4. American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
5. Lee T, von Scheven E, Sandborg C. Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescents. Curr Opin Rheumatol 2001;13:415-21.
6. Mok CC, Lau CS, Wong RWS. Neuropsychiatric manifestations and their clinical associations in Southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2001;28:766-71.
7. Toubi E, Khamashta MA, Panarra A, Hughes GR. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995;99:397-401.
8. Golstein M, Meyer O, Bourgeois P, et al. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies. Clin Exp Rheumatol 1993;11:373-79.
9. Afeltra A, Garzia P, Paola Mitterhofer A, et al. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 2003;61:108-10.
10. Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003;30:985-92.
11. Angelini L, Granata T, Zibordi F, Binelli S, Zorzi G, Besana C. Partial seizures associated with antiphospholipid antibodies in childhood. Neuropediatrics 1998;29:249-53.
12. Eriksson K, Peltola J, Keranen T, Haapala AM, Koivikko M. High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases. Epilepsy Res 2001;46:129-37.
13. Okun MS, Jummani RR, Carney PR. Antiphospholipid-associated recurrent chorea and ballism in a child with cerebral palsy. Pediatr Neurol 2000;23:62-3.
14. Kiechl-Kohlendorfer U, Ellemunter H, Kiechl S. Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood. Neuropediatrics 1999;30:96-8.
15. Berube C, Mitchell L, Silverman E, et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: A cross sectional study. Pediatr Res 1998;44:351-6.
16. Ravelli A, Caporali R, Di Fuccia G, Zonta L, Montecucco C, Martini A. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med 1994;148:398-402.
17. Shergy W, Kredich DW, Pisetsky DS. The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus. J Rheumatol 1998;15:1389-94.
18. Seaman DE, Londino AV Jr, Kent Kwoh C, Medsger TA Jr, Manzi S. Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 1995;96:1040-5.
19. Levy DM, Massicotte MP, Harvey E, Herbert D, Silverman ED. Thromboembolism in paediatric lupus patients. Lupus 2003;12:741-6.
20. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
21. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
22. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68:215-22.
23. Brandt J, Triplett D, Alving B, Scharrer I. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Criteria for the diagnosis of lupus anticoagulant: an update. Thromb Haemost 1995;74:1185-90.
24. Sibbitt WL Jr, Brandt JR, Johnson CR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002;29:1536-42.
25. Nived O, Sturfelt G, Liang MH, De Pablo P. The ACR nomenclature for CNS lupus revisited. Lupus 2004;12:872-6.
26. Sfikakis PP, Mitsikostas DD, Manoussakis MN, Foukaneli D, Moutsopoulos HM. Headache in systemic lupus erythematosus: a controlled study. Br J Rheumatol 1998;37:300-3.
27. Fernandez-Nebro A, Palacios-Munoz R, Gordillo J, et al. Chronic or recurrent headache in patients with systemic lupus erythematosus: a case controls study. Lupus 1999;8:151-6.
28. Mitsikostas DD, Sfikakis PP, Goadsby PJ. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain 2004;127:1200-9.
29. Sastre-Garriga J, Montalban X. APS and the brain. Lupus 2003;12:877-82.
30. Olfat MO, Al-Mayouf SM, Muzaffer MA. Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus. Clin Rheumatol 2004;23:395-9.
31. Brunner HI, Jones OY, Lovell DJ, Johnson AM, Alexander P, Klein-Gitelman MS. Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and disease damage. Lupus 2003;12:600-6.